151 related articles for article (PubMed ID: 8654565)
41. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
42. Functional characterization of ion permeation pathway in the N-type Ca2+ channel.
Wakamori M; Strobeck M; Niidome T; Teramoto T; Imoto K; Mori Y
J Neurophysiol; 1998 Feb; 79(2):622-34. PubMed ID: 9463426
[TBL] [Abstract][Full Text] [Related]
43. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
44. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
Smith DO; Conklin MW; Jensen PJ; Atchison WD
J Physiol; 1995 Aug; 487(1):115-23. PubMed ID: 7473242
[TBL] [Abstract][Full Text] [Related]
45. Specificity of the Lambert-Eaton syndrome antibodies. Downregulation of P/Q-type calcium channels in bovine adrenal chromaffin cells.
Kim YI; Nam TS; Kim SH; Viglione MP; Kim J
Ann N Y Acad Sci; 1998 May; 841():677-83. PubMed ID: 9668313
[No Abstract] [Full Text] [Related]
46. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
Takamori M; Iwasa K; Komai K
Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
[TBL] [Abstract][Full Text] [Related]
47. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity to dihydropyridines, omega-conotoxin and noradrenaline reveals multiple high-voltage-activated Ca2+ channels in rat insulinoma and human pancreatic beta-cells.
Pollo A; Lovallo M; Biancardi E; Sher E; Socci C; Carbone E
Pflugers Arch; 1993 Jun; 423(5-6):462-71. PubMed ID: 7688893
[TBL] [Abstract][Full Text] [Related]
49. Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels.
Martin-Moutot N; el Far O; Leveque C; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M; Seagar MJ
J Physiol Paris; 1993; 87(1):37-41. PubMed ID: 8305896
[TBL] [Abstract][Full Text] [Related]
50. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
51. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
52. Calcium channel currents in acutely dissociated intracardiac neurons from adult rats.
Jeong SW; Wurster RD
J Neurophysiol; 1997 Apr; 77(4):1769-78. PubMed ID: 9114235
[TBL] [Abstract][Full Text] [Related]
53. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Komai K; Iwasa K; Takamori M
J Neurol Sci; 1999 Jul; 166(2):126-30. PubMed ID: 10475106
[TBL] [Abstract][Full Text] [Related]
54. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome.
el Far O; Marquèze B; Leveque C; Martin-Moutôt N; Lang B; Newsom-Davis J; Yoshida A; Takahashi M; Seagar MJ
J Neurochem; 1995 Apr; 64(4):1696-702. PubMed ID: 7891097
[TBL] [Abstract][Full Text] [Related]
55. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
[No Abstract] [Full Text] [Related]
56. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
Verschuuren JJ; Dalmau J; Tunkel R; Lang B; Graus F; Schramm L; Posner JB; Newsom-Davis J; Rosenfeld MR
Neurology; 1998 Feb; 50(2):475-9. PubMed ID: 9484375
[TBL] [Abstract][Full Text] [Related]
57. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
58. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.
Pinto A; Gillard S; Moss F; Whyte K; Brust P; Williams M; Stauderman K; Harpold M; Lang B; Newsom-Davis J; Bleakman D; Lodge D; Boot J
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8328-33. PubMed ID: 9653186
[TBL] [Abstract][Full Text] [Related]
59. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome.
Takamori M
Intern Med; 1999 Feb; 38(2):86-96. PubMed ID: 10225662
[TBL] [Abstract][Full Text] [Related]
60. omega-Conotoxin-sensitive, voltage-operated Ca2+ channels in insulin-secreting cells.
Sher E; Biancardi E; Pollo A; Carbone E; Li G; Wollheim CB; Clementi F
Eur J Pharmacol; 1992 Jun; 216(3):407-14. PubMed ID: 1330583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
